Oxidatively modified proteins in aging and disease

Free Radical Biology and Medicine

Volumn 32, Issue 9, 2002, Pages 797-803

  Beal, M Flint ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

3 Nitrotyrosine; Alzheimer's; Amyotrophic lateral sclerosis; Carbonyls; Dityrosine; Free radical; Huntington's; Parkinson's

Indexed keywords

3 NITROTYROSINE; CARBONYL DERIVATIVE;

AGING; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; DEGENERATIVE DISEASE; DISEASE MARKER; HUMAN; HUNTINGTON CHOREA; NEUROPATHOLOGY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVIEW;

EID: 0036570159     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)00780-3     Document Type: Article

References (74)

1. Acceleration of peroxynitrite oxidations by carbon dioxide
2. Neural roles for heme oxygenase: Contrasts to nitric oxide synthase
3. Carbon dioxide stimulates peroxynitrite-mediated nitration of tyrosine residues and inhibits oxidation of methionine residues of glutamine synthetase: Both modifications mimic effects of adenylylation
4. Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine
5. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis
6. Protein oxidative damage is associated with life expectancy of houseflies
7. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse
8. Oxidative stress and aging in the mongolian gerbil (Meriones unguiculatus)
9. Aging effects of vitamin C on a human lens protein produced in vitro
10. Age-dependent changes of antioxidant activities and markers of free radical damage in human skeletal muscle
11. Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle
12. Excess brain protein oxidation and enzyme of dysfunction in normal aging and Alzheimer disease
13. Age-related changes in oxidized proteins
14. Modification of hepatic proteins in rats exposed to high oxygen concentration
15. Protein oxidation and proteolysis during aging and oxidative stress
16. Prevention of flight activity prolongs the life span of the housefly, Musca domestica, and attenuates the age-associated oxidative damage to specific mitochondrial proteins
17. Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals
18. Oxidative damage during aging targets mitochondrial aconitase
19. Mitochondrial adenine nucleotide translocase is modified oxidatively during aging
20. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain
21. Proteomic method identifies proteins nitrated in vivo during inflammatory challenge
22. Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite
23. Rapid reactions of peroxynitrite with heme-thiolate proteins as the basis for protection of prostacyclin synthase from inactivation by nitration
24. 2 peptide
25. Mitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation
26. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease
27. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation
28. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: The role of Abeta1- 42
29. Oxidative damage in Alzheimer's
30. Dimethylargininase, a nitric oxide regulatory protein, in Alzheimer disease
31. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease
32. Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid
33. Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer's disease
34. Altered glycosylation pattern of proteins in Alzheimer disease
35. Evidence for neuronal oxidative damage in Alzheimer's disease
36. Widespread peroxynitrite-mediated damage in Alzheimer's disease
37. Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain
38. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease
39. Nitric oxide synthase in reactive astrocytes adjacent to beta-amyloid plaques
40. Electrochemical analysis of protein nitrotyrosine and dityrosine in the Alzheimer brain indicates region-specific accumulation
41. Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease
42. Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases [In Process Citation]
43. A generalised increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease
44. Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies
45. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity
46. Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice
47. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons
48. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
49. Protein nitration in Parkinson's disease
50. Detection of nitrosyl complexes in human substantia nigra, in relation to Parkinson's disease
51. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions
52. Induction of a-synuclein aggregation by intracellular nitrative insult
53. Dityrosine cross-linking promotes formation of stable alpha -synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies
54. A-synuclein promotes mitochondrial deficit and oxidative stress
55. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease
56. Neural heme oxygenase-1 expression in idiopathic Parkinson's disease
57. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis
58. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis
59. Oxidative damage to protein in sporadic motor neuron disease spinal cord
60. Oxidative damage and motor neurone disease difficulties in the measurement of protein carbonyls in human brain tissue
61. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients
62. Remarkable increase in cerebrospinal fluid 3-nitrotyrosine in patients with sporadic amyotrophic lateral sclerosis
63. Reduced creatine kinase activity in transgenic amyotrophic lateral sclerosis mice
64. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis
65. Upregulation of protein-tyrosine nitration in the anterior horn cells of amyotrophic lateral sclerosis
66. Colocalization of NOS and SOD1 in neurofilament accumulation within motor neurons of amyotrophic lateral sclerosis: An immunohistochemical study
67. Neuronal nitric oxide synthase immunoreactivity in the spinal cord in amyotrophic lateral sclerosis
68. Glial cells of the spinal cord and subcortical white matter up-regulate neuronal nitric oxide synthase in sporadic amyotrophic lateral sclerosis
69. Increased expression of neuronal nitric oxide synthase spliced variants in reactive astrocytes of amyotrophic lateral sclerosis human spinal cord
70. Increased expression of the pro-inflammatory enzyme cyclooxygenase-2 in amyotrophic lateral sclerosis
71. No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's disease
72. Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal ganglia
73. Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease
74. Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse